Utah Medical Products, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $3.5M | $4.0M | $4.3M | $3.9M | $4.2M | $4.2M | $4.6M | $4.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $171.0K | $156.0K | $158.0K | $155.0K | $155.0K | $155.0K | $158.0K | $152.0K |
| Amortization | $510.0K | $513.0K | $868.0K | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M |
| Stock-Based Compensation | $52.0K | $79.0K | $72.0K | $53.0K | $50.0K | $50.0K | $62.0K | $38.0K |
| Net Cash from Operating Activities | $2.8M | $5.3M | $5.3M | $5.1M | $4.9M | $6.9M | $5.7M | $5.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $110.0K | $22.0K | $90.0K | $186.0K | $320.0K | $43.0K | $38.0K | $321.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-115.0K | $5.0K | $-90.0K | $-186.0K | $-320.0K | $-43.0K | $-38.0K | $-321.0K |
| Financing Activities | ||||||||
| Dividends Paid | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M |
| Stock Repurchases | $6.4M | $3.0M | $0 | $0 | $0 | $0 | — | — |
| Net Cash from Financing Activities | $-7.2M | $-4.0M | $-1.1M | $-1.0M | $-1.0M | $-1.0M | $-920.0K | $-1.0M |
| Net Change in Cash | $-4.6M | $940.0K | $4.7M | $3.6M | $3.7M | $5.9M | $5.5M | $3.3M |
| Free Cash Flow | $2.7M | $5.3M | $5.2M | $4.9M | $4.6M | $6.9M | $5.6M | $5.3M |